Atrás
60
Rango del Día
$24.97
$25.76
Rango de 52 Semanas
$13.53
$36.44
Volumen
1,168,056
Promedio 50D / 200D
$28.35
/
$23.72
Cierre Anterior
$24.63
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -32.1 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | -8.1 | 3.7 |
| Net Margin % | -57.2 | 3.9 |
| Rev Growth 5Y % | 28.1 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$40.86
+62.3%
Low: $26.00
High: $74.00
EPS Futuro
-$4.36
Ingresos Est.
45 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$1.27
-$2.98 – -$0.27
|
710 M | 4 |
| FY2029 |
-$3.23
-$7.60 – -$0.68
|
410 M | 4 |
| FY2028 |
-$4.65
-$7.93 – -$2.94
|
140 M | 10 |
Puntos Clave
Revenue grew 28.13% annually over 5 years — strong growth
Debt/Equity of 0.24 — conservative balance sheet
Negative free cash flow of -360.05M
PEG of 0.42 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 91.88%
Crecimiento
Revenue Growth (5Y)
28.13%
Revenue (1Y)120.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-8.11%
ROIC-18.78%
Net Margin-57.24%
Op. Margin-274.57%
Seguridad
Debt / Equity
0.24
Current Ratio13.09
Interest Coverage-8.77
Valoración
P/E Ratio
-32.05
P/B Ratio2.07
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 120.01% | Revenue Growth (3Y) | -39.17% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 28.13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 139.74M | Net Income (TTM) | -79.99M |
| ROE | -8.11% | ROA | -5.40% |
| Gross Margin | 84.05% | Operating Margin | -274.57% |
| Net Margin | -57.24% | Free Cash Flow (TTM) | -360.05M |
| ROIC | -18.78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 13.09 |
| Interest Coverage | -8.77 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -32.05 | P/B Ratio | 2.07 |
| P/S Ratio | 18.35 | PEG Ratio | 0.42 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.56B | Enterprise Value | 2.56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 139.74M | 63.52M | 377.71M | 60.92M | 51.84M |
| Net Income | -79.99M | -376.74M | -132.53M | -289.09M | -370.64M |
| EPS (Diluted) | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
| Gross Profit | 117.45M | -304.04M | 377.71M | -250.67M | -180.29M |
| Operating Income | -383.69M | -415.57M | -176.49M | -338.48M | -392.47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.48B | 1.10B | 1.46B | 1.34B | 1.47B |
| Total Liabilities | 242.82M | 370.28M | 478.39M | 608.24M | 647.72M |
| Shareholders' Equity | 1.24B | 733.55M | 981.33M | 733.47M | 826.74M |
| Total Debt | 293.88M | 161.43M | 172.69M | 179.01M | 147.64M |
| Cash & Equivalents | 294.94M | 281.97M | 435.90M | 232.77M | 559.99M |
| Current Assets | 1.27B | 878.15M | 1.21B | 1.09B | 1.27B |
| Current Liabilities | 96.94M | 182.07M | 205.57M | 223.60M | 213.44M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#34 of 146
Actividad Reciente
Entró
Full Throttle
Mar 24, 2026